Fosun Pharma’s biopharma unit Shanghai Henlius in Shanghai. Photo: Handout
Fosun Pharma’s biopharma unit Shanghai Henlius in Shanghai. Photo: Handout

China’s pharmaceutical industry will be at the global forefront in the next 5 years, Fosun Pharma chairman says

  • The industry has a solid foundation and strong long-term prospects, Shanghai Fosun Pharmaceutical chairman Wu Yifang says in an interview
  • The company is boosting research investments as it aims to develop technology platforms that will occupy the mainstream 10 years from now, he says

Fosun Pharma’s biopharma unit Shanghai Henlius in Shanghai. Photo: Handout
Fosun Pharma’s biopharma unit Shanghai Henlius in Shanghai. Photo: Handout
READ FULL ARTICLE